Der Anaesthesist

, Volume 56, Issue 12, pp 1286–1288




  1. 1.
    Spalding GJ, Hartrumpf M, Sierig T et al. (2007) „Bedside”-Thrombelastographie. Kostenreduktion in der Herzchirurgie. Anaesthesist 56(8): 765–771PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson L, Quasim I, Soutar R et al. (2006) An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 16(1): 31–39PubMedCrossRefGoogle Scholar
  3. 3.
    Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354(4): 353–365PubMedCrossRefGoogle Scholar
  4. 4.
    Mangano DT, Miao Y, Vuylsteke A et al. (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297(5): 471–479PubMedCrossRefGoogle Scholar
  5. 5.
    Godje O, Gallmeier U, Schelian M et al. (2006) Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 54(1): 26–33PubMedCrossRefGoogle Scholar
  6. 6.
    Blome M, Isgro F, Kiessling AH et al. (2005) Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 93(6): 1101–1107PubMedGoogle Scholar
  7. 7.
    Spalding GJ, Hartrumpf M, Sierig T et al. (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of „bedside“ thrombelastography (ROTEM). Eur J Cardiothorac Surg 31(6): 1052–1057PubMedCrossRefGoogle Scholar
  8. 8.
    Heymann C von, Pruss A, Foer A et al. (2005) Qualitätssicherung Hämotherapie in der Anästhesie. Anaesthesist 54(2): 107–116CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Personalised recommendations